Table 1 Baseline patients characteristics
|  | NA1c (n = 68) | RA1c (n = 69) | DM (n = 79) | P value |
|---|---|---|---|---|
Age, years | 58.4 ± 9.9 | 59.3 ± 9.3 | 59.2 ± 9.2 | 0.849 |
BMI, kg/m2 | 25.1 ± 4.7 | 26.3 ± 3.6 | 26.5 ± 4.5 | 0.343 |
Male sex, n (%) | 55 (80.9) | 53 (76.8) | 64 (81.0) | 0.780 |
Smoking, n (%) | 48 (70.6) | 42 (60.9) | 50 (63.3) | 0.462 |
Hypertension, n (%) | 24 (35.3) | 31 (44.9) | 44 (55.7) | 0.046* |
Dyslipidemia, n (%) | 29 (42.6) | 45 (65.2) | 47 (59.5) | 0.021* |
Statin, n (%) | 12 (17.6) | 17 (24.6) | 19 (24.1) | 0.546 |
Prior MI, n (%) | 12 (17.6) | 19 (27.5) | 17 (21.5) | 0.373 |
Prior PCI, n (%) | 11 (16.2) | 15 (21.7) | 16 (20.3) | 0.695 |
Chronic kidney disease, n (%) | 3 (4.4) | 2 (2.9) | 3 (3.8) | 0.895 |
STEMI, n (%) | 36 (52.9) | 40 (58.0) | 44 (55.7) | 0.839 |
CK-MB, μg/L | 27.7 ± 54.0 | 42.0 ± 116.4 | 42.4 ± 130.0 | 0.652 |
TnI, μg/L | 7.1 ± 21.7 | 36.9 ± 120.7 | 22.1 ± 66.9 | 0.098 |
Hs-CRP, mg/dL | 5.2 ± 4.8 | 6.4 ± 5.3 | 5.0 ± 5.1 | 0.264 |
Creatinine, μmol/L | 76.9 ± 20.9 | 78.1 ± 19.8 | 78.4 ± 22.2 | 0.899 |
TC, mg/dL | 157.3 ± 37.0 | 172.1 ± 47.5 | 164.5 ± 45.8 | 0.195 |
TG, mg/dL | 117.5 ± 47.4 | 159.1 ± 94.0 | 146.5 ± 84.9 | 0.019 |
LDL-C, mg/dL | 100.6 ± 35.4 | 112.8 ± 42.3 | 106.6 ± 39.6 | 0.248 |
HDL-C, mg/dL | 48.2 ± 10.7 | 46.5 ± 10.4 | 47.5 ± 10.0 | 0.653 |
Insulin, n (%) | 0 | 0 | 7 | Â |
Oral hypoglycemic agents, n (%) | 0 | 0 | 11 | Â |